Economics first process development

Mirrored equipment and capabilities, processes and analytical approaches enable seamless and rapid scale up and tech transfer projects to serve clients worldwide.

End 2 end, from gene to commercial CDMO services for biologics 

Fast and price competitive tech transfers and scale up services

Knowing how to choose a biologics CDMO matters as it’s one of the most important strategic decisions any biotech or pharma company will make. The right partner can accelerate development, reduce technical and regulatory risk, and support a smoother path to commercialization. The wrong one can introduce delays, increase costs, and create challenges that are difficult to resolve later in the program.

Rezon Bio is a science-driven, price-competitive contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian biologics. Headquartered in Poland, Rezon Bio offers integrated solutions spanning cell line development, commercial drug substance manufacturing, and drug product development. The company operates with state-of-the-art facilities, world-class teams, and a proven track record of regulatory and commercial success. 

New brand with proven track record – EMA and FDA-audited mirrored-capability sites in Poland provide an accelerated path from development to commercialization.